Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy ; volume:10 ; number:1 ; day:6 ; month:2 ; year:2019 ; pages:1-17 ; date:12.2019
Nature Communications ; 10, Heft 1 (6.2.2019), 1-17, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Haikala, Heidi M.
Anttila, Johanna M.
Marques, Elsa
Raatikainen, Tiina
Ilander, Mette
Hakanen, Henna
Ala-Hongisto, Hanna
Savelius, Mariel
Balboa, Diego
Eyß, Björn von
Eskelinen, Vilja
Munne, Pauliina
Nieminen, Anni I.
Otonkoski, Timo
Schüler, Julia
Laajala, Teemu D.
Aittokallio, Tero
Sihto, Harri
Mattson, Johanna
Heikkilä, Päivi
Leidenius, Marjut
Joensuu, Heikki
Mustjoki, Satu
Kovanen, Panu
Eilers, Martin
Leverson, Joel D.
Klefström, Juha
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-08541-2
- URN
-
urn:nbn:de:101:1-2019032014592659979439
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
20.03.2026, 3:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haikala, Heidi M.
- Anttila, Johanna M.
- Marques, Elsa
- Raatikainen, Tiina
- Ilander, Mette
- Hakanen, Henna
- Ala-Hongisto, Hanna
- Savelius, Mariel
- Balboa, Diego
- Eyß, Björn von
- Eskelinen, Vilja
- Munne, Pauliina
- Nieminen, Anni I.
- Otonkoski, Timo
- Schüler, Julia
- Laajala, Teemu D.
- Aittokallio, Tero
- Sihto, Harri
- Mattson, Johanna
- Heikkilä, Päivi
- Leidenius, Marjut
- Joensuu, Heikki
- Mustjoki, Satu
- Kovanen, Panu
- Eilers, Martin
- Leverson, Joel D.
- Klefström, Juha
- SpringerLink (Online service)
Other Objects (12)
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer
Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)- LLO immunotherapy
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer
Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)- LLO immunotherapy
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer
Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)- LLO immunotherapy
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy